Rate My Professor Michael Jenkinson

Professor Michael Jenkinson, MB ChB, PhD, FRCSEd (Neuro.Surg), is the Sir John Fisher Foundation / RCSEng Chair of Surgical Trials and Professor of Neurosurgery in the Faculty of Health and Life Sciences at the University of Liverpool. He qualified with an MB ChB from the University of Liverpool in 1998 and completed neurosurgical training at The Walton Centre, Liverpool, between 2001 and 2010. This training included three years as a clinical research fellow, during which he obtained his PhD in Neuroscience on the imaging and biology of oligodendroglial tumours. He was appointed Consultant Neurosurgeon at The Walton Centre in March 2010 and Professor of Neurosurgery at the University of Liverpool in 2019. Jenkinson sub-specialises in neurosurgical oncology, focusing on meningiomas and intrinsic brain tumours, awake craniotomy, intraoperative brain mapping for low-grade gliomas, and midline approaches to intraventricular and deep intrinsic tumours.

His research specializations include meningioma management encompassing incidental tumours, seizures, and quality of life; imaging and biology of brain metastases; and interventional clinical trials in neurosurgery and neuro-oncology. He has received grants from the MRC, Brain Tumour Charity, and NIHR. As chief investigator, he leads NIHR-funded trials including ROAM (Radiation versus Observation following surgical resection of Atypical Meningioma), STOP 'EM (Surgeons Trial of Prophylaxis for Epilepsy in Meningioma), SPRING (Seizure Prophylaxis in Glioma), and ReStart (Restarting DOAC after TBI), and is co-investigator on FUTURE GB and PROSSPER. He led the KEATING pilot study on ketogenic diets for glioblastoma patients and was co-chief investigator on the BASICS trial, which showed antibiotic-impregnated ventriculoperitoneal shunt catheters reduce infection rates from 6% to 2%, saving £135,000 per infection averted and establishing them as standard care in UK neurosurgery. Jenkinson holds leadership positions such as Vice President for Research, Impact and Innovation at the Society of British Neurological Surgeons, National Neurosurgery Specialty Lead for the Royal College of Surgeons of England, and Chair of the EORTC Meningioma Committee. In 2025, he received the Vilhelm Magnus Medal. Key publications include the EANO guideline on meningioma diagnosis and management (2021, Neuro-Oncology), BASICS trial results (2019), and a clinical tool for incidental meningioma management (2026, JAMA Oncology).